Cargando…
MET Oncogene Controls Invasive Growth by Coupling with NMDA Receptor
SIMPLE SUMMARY: The MET oncogene, encoding the tyrosine kinase receptor for a hepatocyte growth factor (HGF), plays a key role in the onset and progression of aggressive forms of breast cancer. Recently, it was found that the glutamate receptor, which has a well-known role in the nervous system, is...
Autores principales: | Gallo, Simona, Vitacolonna, Annapia, Comoglio, Paolo, Crepaldi, Tiziana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496780/ https://www.ncbi.nlm.nih.gov/pubmed/36139568 http://dx.doi.org/10.3390/cancers14184408 |
Ejemplares similares
-
NMDA Receptor and Its Emerging Role in Cancer
por: Gallo, Simona, et al.
Publicado: (2023) -
HGF and MET: From Brain Development to Neurological Disorders
por: Desole, Claudia, et al.
Publicado: (2021) -
ERK: A Key Player in the Pathophysiology of Cardiac Hypertrophy
por: Gallo, Simona, et al.
Publicado: (2019) -
The PSI Domain of the MET Oncogene Encodes a Functional Disulfide Isomerase Essential for the Maturation of the Receptor Precursor
por: Altintas, Dogus Murat, et al.
Publicado: (2022) -
Anti-Differentiation Effect of Oncogenic Met Receptor in Terminally-Differentiated Myotubes
por: Sala, Valentina, et al.
Publicado: (2015)